Atlas Trials

Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer

Clinical trial NCT05244577 · UNKNOWN

Trial details

NCT number
NCT05244577
Sponsor
Shi Yanxia
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
OlanzapineCINVTesticular Cancer by AJCC V6 and V7 StageCisplatin
Start date
2022-01-18
Primary completion
2023-12-31
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.